The Reporting Items for Patent Landscapes statement
- 9 November 2018
- journal article
- editorial
- Published by Springer Nature in Nature Biotechnology
- Vol. 36 (11) , 1043-1047
Abstract
The reporting quality of patent landscapes is inadequate. The Reporting Items for Patent Landscapes (RIPL) checklist can improve reporting quality.Keywords
This publication has 25 references indexed in Scilit:
- Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journalsCochrane Database of Systematic Reviews, 2012
- Describing reporting guidelines for health research: a systematic reviewJournal of Clinical Epidemiology, 2011
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- Guidance for Developers of Health Research Reporting GuidelinesPLOS Medicine, 2010
- Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using AnimalsPLOS ONE, 2009
- Can literature analysis identify innovation drivers in drug discovery?Nature Reviews Drug Discovery, 2009
- What is missing from descriptions of treatment in trials and reviews?BMJ, 2008
- A Systematic Evaluation of the Impact of STRICTA and CONSORT Recommendations on Quality of Reporting for Acupuncture TrialsPLOS ONE, 2008
- Epidemiology and Reporting Characteristics of Systematic ReviewsPLOS Medicine, 2007
- Topical liposome drugs to come: What the patent literature tells usJournal of the American Academy of Dermatology, 1991